We are live on ! Find out more
MSFP

Mark Sheptoff Financial Planning Portfolio holdings

AUM $189M
1-Year Est. Return 28.82%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+28.82%
3 Year Est. Return
+85.85%
5 Year Est. Return
+121.15%
10 Year Est. Return
+416.47%
AUM
$174M
AUM Growth
-$1.53M
Cap. Flow
-$6.27M
Cap. Flow %
-3.6%
Top 10 Hldgs %
50.55%
Holding
403
New
43
Increased
40
Reduced
75
Closed
24

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$846K
2
BAC icon
Bank of America
BAC
+$769K
3
DT icon
Dynatrace
DT
+$398K
4
JNJ icon
Johnson & Johnson
JNJ
+$342K
5
DE icon
Deere & Co
DE
+$213K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.5M
2
FUTU icon
Futu Holdings
FUTU
+$1.06M
3
ERIC icon
Ericsson
ERIC
+$1.02M
4
MRK icon
Merck
MRK
+$770K
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$636K

Sector Composition

Rank Sector Weight
1 Healthcare 26.64%
2 Consumer Staples 18.23%
3 Technology 16.27%
4 Utilities 13.18%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVA icon
176
DaVita
DVA
$11.7B
$43K 0.02%
400
PANW icon
177
Palo Alto Networks
PANW
$297B
$43K 0.02%
798
TMO icon
178
Thermo Fisher Scientific
TMO
$220B
$43K 0.02%
95
APTV icon
179
Aptiv
APTV
$10.3B
$41K 0.02%
300
STLD icon
180
Steel Dynamics
STLD
$37.6B
$41K 0.02%
+800
New +$33.7K
EW icon
181
Edwards Lifesciences
EW
$51.7B
$40K 0.02%
480
RING icon
182
iShares MSCI Global Gold Miners ETF
RING
$2.56B
$40K 0.02%
1,450
ACB
183
Aurora Cannabis
ACB
$185M
$39K 0.02%
414
BYND icon
184
Beyond Meat
BYND
$277M
$39K 0.02%
300
WST icon
185
West Pharmaceutical
WST
$24.9B
$39K 0.02%
138
K
186
DELISTED
Kellanova
K
$38K 0.02%
+639
New +$35.7K
OTEX icon
187
Open Text
OTEX
$6.04B
$38K 0.02%
800
LMND icon
188
Lemonade
LMND
$4.1B
$37K 0.02%
400
-450
-53% -$58.1K
RF icon
189
Regions Financial
RF
$26.8B
$37K 0.02%
1,800
-700
-28% -$13.7K
XLNX
190
DELISTED
Xilinx Inc
XLNX
$37K 0.02%
300
GDL
191
GDL Fund
GDL
$92.1M
$36K 0.02%
4,000
+3,000
+300% +$26.6K
VOO icon
192
Vanguard S&P 500 ETF
VOO
$1.01T
$36K 0.02%
100
-100
-50% -$35.5K
AXP icon
193
American Express
AXP
$230B
$35K 0.02%
+250
New +$33K
VTRS icon
194
Viatris
VTRS
$18.9B
$35K 0.02%
2,529
+2,215
+705% +$36.1K
SCHM icon
195
Schwab US Mid-Cap ETF
SCHM
$15.1B
$34K 0.02%
1,377
TWLO icon
196
Twilio
TWLO
$36.6B
$34K 0.02%
100
PSX icon
197
Phillips 66
PSX
$81.4B
$33K 0.02%
410
EVRG icon
198
Evergy
EVRG
$19.2B
$32K 0.02%
538
FTV icon
199
Fortive
FTV
$18.6B
$32K 0.02%
597
-133
-18% -$6.88K
MTUS icon
200
Metallus
MTUS
$898M
$32K 0.02%
2,756

Similar funds

Mark Sheptoff Financial Planning's Q1 2021 Portfolio in Review

As of Q1 2021, Mark Sheptoff Financial Planning held 403 positions worth $174M, down 0.87% from $176M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Mark Sheptoff Financial Planning withdrew a net $6.27M in Q1 2021, closing 24 positions and reducing 75 holdings. Its most notable exit was Graham Holdings Company, an estimated $179K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Mark Sheptoff Financial Planning opened a new position in Direxion Daily S&P 500 Bear 3x ETF worth $163K.

  • Mark Sheptoff Financial Planning's largest Q1 2021 buy was Direxion Daily S&P 500 Bear 3x ETF: 520 shares worth $163K.
  • Mark Sheptoff Financial Planning added most to Constellation Brands in Q1 2021, an estimated $846K increase.
  • Mark Sheptoff Financial Planning's biggest Q1 2021 reduction was Pfizer, cutting an estimated $1.5M.
  • Mark Sheptoff Financial Planning fully exited Graham Holdings Company in Q1 2021, selling an estimated $179K.
  • Mark Sheptoff Financial Planning's ten largest holdings make up 51% of its $174M portfolio in Q1 2021.
  • Mark Sheptoff Financial Planning opened 43 new positions and closed 24 in Q1 2021.
  • Mark Sheptoff Financial Planning's portfolio value fell 0.87% quarter-over-quarter to $174M.

Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2021, filed 11 May 2021.